Encompass Health Corporation $EHC Holdings Cut by Van Lanschot Kempen Investment Management N.V.

Key Points

Error: Response status code does not indicate success: 429 (Too Many Requests).

Van Lanschot Kempen Investment Management N.V. cut its stake in Encompass Health Corporation (NYSE:EHC - Free Report) by 21.6% in the 1st quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 432,345 shares of the company's stock after selling 119,079 shares during the period. Van Lanschot Kempen Investment Management N.V. owned approximately 0.43% of Encompass Health worth $43,788,000 at the end of the most recent reporting period.

Several other institutional investors and hedge funds have also made changes to their positions in the stock. Hsbc Holdings PLC boosted its holdings in shares of Encompass Health by 85.1% in the first quarter. Hsbc Holdings PLC now owns 77,235 shares of the company's stock valued at $7,778,000 after acquiring an additional 35,513 shares in the last quarter. Fuller & Thaler Asset Management Inc. boosted its holdings in shares of Encompass Health by 11.9% in the first quarter. Fuller & Thaler Asset Management Inc. now owns 1,541,477 shares of the company's stock valued at $156,121,000 after acquiring an additional 163,400 shares in the last quarter. Quantbot Technologies LP bought a new position in shares of Encompass Health in the first quarter valued at approximately $184,000. Aptus Capital Advisors LLC boosted its holdings in shares of Encompass Health by 12.6% in the first quarter. Aptus Capital Advisors LLC now owns 99,828 shares of the company's stock valued at $10,111,000 after acquiring an additional 11,132 shares in the last quarter. Finally, Northern Trust Corp boosted its holdings in shares of Encompass Health by 2.4% in the first quarter. Northern Trust Corp now owns 1,057,338 shares of the company's stock valued at $107,087,000 after acquiring an additional 24,437 shares in the last quarter. 97.25% of the stock is currently owned by institutional investors.

Encompass Health Trading Down 0.5%

Encompass Health stock traded down $0.67 during midday trading on Friday, reaching $122.76. The stock had a trading volume of 798,000 shares, compared to its average volume of 895,065. The firm's fifty day simple moving average is $116.38 and its two-hundred day simple moving average is $110.27. Encompass Health Corporation has a twelve month low of $87.85 and a twelve month high of $124.67. The company has a debt-to-equity ratio of 0.76, a current ratio of 1.06 and a quick ratio of 1.06. The firm has a market cap of $12.36 billion, a price-to-earnings ratio of 24.02, a PEG ratio of 2.16 and a beta of 0.86.

Encompass Health (NYSE:EHC - Get Free Report) last posted its quarterly earnings data on Monday, August 4th. The company reported $1.40 EPS for the quarter, topping analysts' consensus estimates of $1.20 by $0.20. Encompass Health had a net margin of 9.22% and a return on equity of 17.83%. The firm had revenue of $1.46 billion during the quarter, compared to analyst estimates of $1.43 billion. During the same quarter last year, the business posted $1.11 EPS. The company's revenue was up 12.0% on a year-over-year basis. Encompass Health has set its FY 2025 guidance at 5.120-5.340 EPS. Equities analysts anticipate that Encompass Health Corporation will post 4.8 EPS for the current fiscal year.

Encompass Health Increases Dividend

The business also recently announced a quarterly dividend, which will be paid on Wednesday, October 15th. Shareholders of record on Wednesday, October 1st will be given a $0.19 dividend. This represents a $0.76 dividend on an annualized basis and a yield of 0.6%. The ex-dividend date is Wednesday, October 1st. This is a positive change from Encompass Health's previous quarterly dividend of $0.17. Encompass Health's payout ratio is currently 14.87%.

Wall Street Analyst Weigh In

Several research analysts have recently issued reports on EHC shares. UBS Group increased their price objective on shares of Encompass Health from $130.00 to $140.00 and gave the company a "buy" rating in a report on Wednesday, August 6th. KeyCorp raised their target price on shares of Encompass Health from $122.00 to $135.00 and gave the stock an "overweight" rating in a report on Tuesday, May 27th. Wall Street Zen cut shares of Encompass Health from a "strong-buy" rating to a "buy" rating in a report on Friday, June 6th. Royal Bank Of Canada raised their target price on shares of Encompass Health from $110.00 to $125.00 and gave the stock an "outperform" rating in a report on Monday, April 28th. Finally, Stephens upgraded shares of Encompass Health from an "overweight" rating to a "strong-buy" rating and set a $135.00 target price for the company in a report on Thursday, June 5th. One equities research analyst has rated the stock with a Strong Buy rating and six have given a Buy rating to the company's stock. According to MarketBeat, the company presently has a consensus rating of "Buy" and an average target price of $134.00.

Encompass Health Company Profile

Encompass Health Corporation provides post-acute healthcare services in the United States and Puerto Rico. It owns and operates inpatient rehabilitation hospitals that provide medical, nursing, therapy, and ancillary services. The company provides specialized rehabilitative treatment on an inpatient basis to patients who have experienced physical or cognitive disabilities or injuries due to medical conditions, such as strokes, hip fractures, and various debilitating neurological conditions.